Deubiquitinating enzyme USP33/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration.
Slit regulates migration of not only neurons, but also nonneuronal cells, such as leukocytes and cancer cells. Slit effect on cancer cell migration has not been well-characterized. In this study, we used several different assays to examine Slit effect on breast cancer cell migration in vitro. We show that ubiquitin-specific protease 33 (USP33)/VDU1, originally identified as a von Hippel-Lindau tumor suppressor (VHL) protein-interacting deubiquitinating enzyme, binds to the Robo1 receptor, and that USP33 is required for Slit responsiveness in breast cancer cells. Slit induces redistribution of Robo1 from intracellular compartments to the plasma membrane in a USP33-dependent manner. Slit impairs directional migration of breast cancer cells without affecting their migration speed. This inhibitory effect is Robo-mediated and USP33-dependent. These data uncover a previously unknown function of USP33 and reveal a new player in Slit-Robo signaling in cancer cell migration.
Yuasa-Kawada
Junichi
J
Department of Neurology, Lurie Cancer Center, Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Kinoshita-Kawada
Mariko
M
Rao
Yi
Y
Wu
Jane Y
JY
D015153:Blotting, Western; D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D002460:Cell Line; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000235:genetics / Q000502:physiology*; D054377:Chemokine CXCL12 / Q000378:metabolism; D002633:Chemotaxis; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D047468:Immunoprecipitation; D036341:Intercellular Signaling Peptides and Proteins / Q000235:genetics / Q000378:metabolism*; D022101:Microtubule-Organizing Center / Q000378:metabolism; D008870:Microtubules / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000235:genetics / Q000378:metabolism*; D034741:RNA, Small Interfering / Q000235:genetics; D019718:Receptors, CXCR4 / Q000235:genetics / Q000378:metabolism; D011971:Receptors, Immunologic / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction; D013314:Stress, Mechanical; D014162:Transfection; D043222:Ubiquitin Thiolesterase / Q000235:genetics / Q000378:metabolism*; D000097905:Roundabout Proteins; D000098552:Slit Homolog 2 Protein
D054377:Chemokine CXCL12; D036341:Intercellular Signaling Peptides and Proteins; D009419:Nerve Tissue Proteins; D034741:RNA, Small Interfering; D019718:Receptors, CXCR4; D011971:Receptors, Immunologic; D043222:Ubiquitin Thiolesterase; D000097905:Roundabout Proteins; D000098552:Slit Homolog 2 Protein; C527276:CXCR4 protein, human; C449799:USP33 protein, human
Oncogene. 2006 Aug 24;25(37):5103-12
16636676
Cell. 2001 Oct 19;107(2):209-21
11672528
J Biol Chem. 2002 Feb 15;277(7):4656-62
11739384
Nature. 2003 Aug 14;424(6950):793-6
12917689
Cell. 2005 Dec 2;123(5):773-86
16325574
Nature. 2003 Aug 14;424(6950):797-801
12917690
Cancer Res. 2003 Mar 1;63(5):1054-8
12615722
Nat Rev Cancer. 2004 Dec;4(12):978-87
15573119
J Biol Chem. 2008 Sep 26;283(39):26624-33
18611862
J Cell Biol. 1981 Nov;91(2 Pt 1):589-94
7309800
Trends Cell Biol. 2006 Nov;16(11):551-9
16996268
Nature. 2004 Apr 1;428(6982):1 p  following 486
15058298
J Cell Sci. 1991 Aug;99 ( Pt 4):769-75
1770004
Physiol Rev. 1946 Jul;26(3):319-36
20993553
Cell. 1999 Mar 19;96(6):795-806
10102268
Int J Cancer. 2003 Jan 20;103(3):306-15
12471613
J Clin Invest. 2003 Jul;112(2):189-96
12865408
Curr Opin Genet Dev. 2002 Oct;12(5):583-91
12200164
Annu Rev Cell Dev Biol. 2003;19:141-72
14570567
Nature. 2005 Jul 28;436(7050):518-24
16049480
J Cell Biol. 1999 Nov 1;147(3):577-88
10545501
Cell. 1999 Mar 19;96(6):807-18
10102269
Cell. 1988 Dec 23;55(6):1047-59
3144436
J Biol Chem. 2004 Mar 5;279(10):9115-24
14645233
Nature. 2003 Aug 14;424(6950):801-5
12917691
Cancer Res. 2002 Oct 15;62(20):5874-80
12384551
J Neurosci. 2003 Jun 15;23(12):5170-7
12832541
Nature. 2001 May 24;411(6836):494-8
11373684
Nature. 2001 Apr 19;410(6831):948-52
11309622
Cell. 2001 Aug 24;106(4):489-98
11525734
Oncogene. 2003 Jul 17;22(29):4611-6
12881718
Genes Dev. 2002 Dec 1;16(23):2973-84
12464628
Nat Rev Cancer. 2004 Jul;4(7):540-50
15229479
Biochim Biophys Acta. 2004 Nov 29;1695(1-3):189-207
15571815
Breast Cancer Res Treat. 2007 Dec;106(3):333-42
17268810
Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3257-64
16740745
Cell. 1999 Mar 19;96(6):785-94
10102267
Nat Rev Neurosci. 2003 Dec;4(12):941-56
14682358
Cell. 1998 Jan 23;92(2):205-15
9458045
Methods Mol Biol. 2005;294:31-41
15576903
Science. 2002 Dec 6;298(5600):1959-64
12471249
J Leukoc Biol. 2007 Sep;82(3):465-76
17565045
Dev Biol. 2005 Apr 1;280(1):26-37
15766745
J Cell Biol. 2004 Aug 16;166(4):487-92
15314065
Nature. 1974 May 31;249(456):450-2
4834231
Annu Rev Neurosci. 2003;26:509-63
12677003
Biochem Biophys Res Commun. 2002 Jun 14;294(3):700-9
12056827
Nature. 1999 Jul 22;400(6742):331-6
10432110
Br J Cancer. 2004 Dec 13;91(12):2071-8
15534609
Nature. 2002 Apr 11;416(6881):648-53
11923872
Nature. 2001 Mar 1;410(6824):50-6
11242036
Nat Rev Cancer. 2008 Aug;8(8):618-31
18633355
EMBO Rep. 2005 Apr;6(4):373-8
15776016
Annu Rev Biochem. 1998;67:425-79
9759494
Oncogene. 1998 Oct 1;17(13):1723-9
9796701
Nature. 2005 Jul 14;436(7048):193-200
16015319